Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Medicare Part B

Is Your Part B Bill About to Jump Over $600 a Month Because of IRMAA?

Medicare Part B is a lifeline for many people, but the cost can be a shock—especially if you get hit with IRMAA. If you’re seeing...

Saving Advice

Plan for Higher Health Care Costs in 2026: Projected Medicare Part B and Part D Premiums

In 2026, Medicare participants will pay more for their health care. Part B costs are expected to rise more than 10%. Here's what you can do.

Kiplinger

Medicare Part B is getting more expensive and outpacing inflation. Here's what you can expect to pay in 2025

The increase “is mainly due to projected price changes and assumed utilization increases that are consistent with historical experience,” according to the Centers for Medicare and Medicaid.

Fortune

From analysis to the latest developments in health,
read the most diverse news in one place.

Medicare Part B Premium Hike Outpaces 2025 Social Security COLA, Tightening Seniors' Monthly Budgets

Medicare Part B Premiums will increase by 5.9% to $185 monthly, which will be deducted from Social Security checks starting January 2025.

International Business Times UK

Older adults 65+ should get flu shots earlier in the season. Here’s why they also need stronger vaccines

Two flu vaccines are FDA-approved exclusively for people 65 and older, who are at higher risk of severe infection.

Fortune

Is Your IRA an IOU to the IRS? Three Retirement Tax Strategies

These steps, including converting to Roth IRAs, using a Roth 401(k) and leveraging life insurance and annuities, can help reduce your taxes in retirement.

Kiplinger

Medicare Premiums 2024: IRMAA for Parts B and D

Kiplinger

Read news from The Economist, FT, and more,
with one subscription

Deutsche Bank Sees Potential 'Dramatic Negative Inflection Point' For Rite Aid

Ahead of the Company's fiscal Q4 results on April 14, Deutsche Bank downgraded Rite Aid Corporation (NYSE:RAD) to Sell from Hold with a price target of $1, down from $16. Analyst George Hill believes COVID has "hastened the decline" for the Company, and he sees the potential for a "dramatic negative inflection point"…

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Social Security Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.